Back
EHRA Premium Access

Novel biomarkers in cardiac resynchronization therapy: Hepatocyte growth factor is an independent predictor of clinical outcome

Session: Poster session 2 - CRT
Topic: Resynchronization Therapy
Speaker: Doctor P. Perge (Budapest, HU)
Event: EHRA 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Peter Perge

Semmelweis University, Budapest (Hungary)
1 presentation
0 follower

19 more presentations in this session

Real World Data: Improvement of echocardiographic parameters, response and quality of life to Cardiac Resynchronization Therapy (CRT) continues up to 12 months after implantation

Speaker: Doctor F. Schiedat (Gelsenkirchen, DE)

Access
Abstract
Like
Thumbnail

Baseline characteristics and outcome of the resynchronization therapy in patients with valvular heart disease: single-center experience.

Speaker: Doctor T. Boumedien (Algiers, DZ)

Access
Abstract
Like
Thumbnail

Sleep apnea detection by a cardiac resynchronization device integrated thoracic impedance sensor - a validation study against the gold standard polysomnography

Speaker: Doctor F. Barbieri (Berlin, DE)

Access
Abstract
Like
Thumbnail

A super outcome to a super response

Speaker: Doctor V. Marinho (Coimbra, PT)

Access
Abstract
Slides
Like
Thumbnail

Non-invasively assessed coronary flow reserve predicts survival in patients treated with cardiac resynchronization therapy

Speaker: Doctor V. Jovanovic (Belgrade, RS)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 2 - CRT

Speakers: Doctor P. Perge, Doctor F. Schiedat, Doctor T. Boumedien, Doctor F. Barbieri, Doctor V. Marinho...
Access
Like
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources